TG Therapeutics’ highly potential pipeline, is poised to fire up the market in the year 2021
TG Therapeutic (TGTX) is a biotechnology company focused on cancer & autoimmune disease with registration programs ongoing in: Chronic Lymphocytic Leukemia (CLL) Marginal Zone Lymphoma (MZL) Follicular Lymphoma (FL) Multiple Sclerosis (MS) In June 2020 […]